Back to Search
Start Over
A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors.
- Source :
- mAbs; Jan-Dec2020, Vol. 12 Issue 1, p1-13, 13p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 19420862
- Volume :
- 12
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- mAbs
- Publication Type :
- Academic Journal
- Accession number :
- 148210135
- Full Text :
- https://doi.org/10.1080/19420862.2020.1773751